TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 36 filers reported holding TALIS BIOMEDICAL CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $39 | +8.3% | 79,880 | -1.7% | 0.00% | – |
| Q4 2022 | $36 | -99.9% | 81,280 | +1.8% | 0.00% | – |
| Q3 2022 | $54,000 | -16.9% | 79,880 | 0.0% | 0.00% | – |
| Q2 2022 | $65,000 | +306.2% | 79,880 | +601.9% | 0.00% | – |
| Q1 2022 | $16,000 | -63.6% | 11,380 | +3.1% | 0.00% | – |
| Q4 2021 | $44,000 | -64.8% | 11,035 | -44.9% | 0.00% | -100.0% |
| Q3 2021 | $125,000 | -43.4% | 20,035 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $221,000 | -14.0% | 20,035 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $257,000 | – | 20,035 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 2,235,783 | $1,073,176 | 0.05% |
| WELLS FARGO & COMPANY/MN | 174 | $84 | 0.00% |
| NORTHERN TRUST CORP | 27,860 | $13,373 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 140,530 | $67,454 | 0.00% |
| STATE STREET CORP | 47,436 | $22,769 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 91,463 | $43,902 | 0.00% |
| DEUTSCHE BANK AG\ | 45,294 | $21,741 | 0.00% |
| MORGAN STANLEY | 61,857 | $29,691 | 0.00% |
| BlackRock Inc. | 76,307 | $36,628 | 0.00% |